JP2008508253A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008508253A5 JP2008508253A5 JP2007523167A JP2007523167A JP2008508253A5 JP 2008508253 A5 JP2008508253 A5 JP 2008508253A5 JP 2007523167 A JP2007523167 A JP 2007523167A JP 2007523167 A JP2007523167 A JP 2007523167A JP 2008508253 A5 JP2008508253 A5 JP 2008508253A5
- Authority
- JP
- Japan
- Prior art keywords
- ccr2
- therapeutic
- administering
- therapeutic agent
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59268304P | 2004-07-30 | 2004-07-30 | |
| PCT/IB2005/002162 WO2006013427A2 (en) | 2004-07-30 | 2005-07-18 | Treatment of ccr2 mediated diseases or disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008508253A JP2008508253A (ja) | 2008-03-21 |
| JP2008508253A5 true JP2008508253A5 (cg-RX-API-DMAC7.html) | 2008-08-14 |
Family
ID=35207829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007523167A Withdrawn JP2008508253A (ja) | 2004-07-30 | 2005-07-18 | Ｃｃｒ２を介した疾患又は障害の治療法 |
Country Status (14)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7671062B2 (en) | 2006-07-28 | 2010-03-02 | Bristol-Myers Squibb Company | Modulators of chemokine receptor activity, crystalline forms and process |
| US7629351B2 (en) | 2006-07-28 | 2009-12-08 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process |
| US7687508B2 (en) | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| RU2547595C2 (ru) | 2008-08-18 | 2015-04-10 | Пфайзер Инк | Антитела против ccr2 |
| US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| US9726666B2 (en) | 2011-06-13 | 2017-08-08 | Tla Targeted Immunotherapies Ab | Diagnosing and treating inflammatory diseases |
| ES2636679T3 (es) * | 2011-06-27 | 2017-10-06 | Université Pierre Et Marie Curie (Paris 6) | Péptidos antagonistas de CCR2 |
| WO2022235440A1 (en) * | 2021-04-21 | 2022-11-10 | The United States Government As Represented By The Department Of Veterans Affairs | Method for treating traumatic brain injury, spinal cord injury, or stroke using small molecule inhibitors of ccr2 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6312689B1 (en) * | 1998-07-23 | 2001-11-06 | Millennium Pharmaceuticals, Inc. | Anti-CCR2 antibodies and methods of use therefor |
| FR2792837B1 (fr) * | 1999-04-29 | 2001-07-13 | Centre Nat Rech Scient | Medicaments utiles pour le traitement des troubles de la regulation de la masse adipeuse et des maladies associees aux troubles de la production de leptine |
| US20050245537A1 (en) * | 2002-04-24 | 2005-11-03 | Noboru Tsuchimori | Use of compounds having ccr antagonism |
| EP1646392A4 (en) * | 2003-07-15 | 2007-02-28 | Merck & Co Inc | 7- and 8-membered heterocyclic cyclopentyl-benzylamide modulators of the chemokine-receptor activity |
| KR20080052683A (ko) * | 2003-12-18 | 2008-06-11 | 인사이트 코포레이션 | 케모킨 수용체의 조절제로서의3-사이클로알킬아미노피롤리딘 유도체 |
-
2005
- 2005-07-18 MX MX2007001204A patent/MX2007001204A/es unknown
- 2005-07-18 RU RU2007103332/14A patent/RU2007103332A/ru not_active Application Discontinuation
- 2005-07-18 BR BRPI0513953-8A patent/BRPI0513953A/pt not_active IP Right Cessation
- 2005-07-18 KR KR1020087010937A patent/KR20080044360A/ko not_active Ceased
- 2005-07-18 CA CA002575612A patent/CA2575612A1/en not_active Abandoned
- 2005-07-18 JP JP2007523167A patent/JP2008508253A/ja not_active Withdrawn
- 2005-07-18 CN CNA2005800276608A patent/CN101005855A/zh active Pending
- 2005-07-18 WO PCT/IB2005/002162 patent/WO2006013427A2/en not_active Ceased
- 2005-07-18 AU AU2005268545A patent/AU2005268545A1/en not_active Abandoned
- 2005-07-18 EP EP05777347A patent/EP1778285A2/en not_active Withdrawn
- 2005-09-16 US US11/658,989 patent/US20090196823A1/en not_active Abandoned
-
2007
- 2007-01-11 IL IL180675A patent/IL180675A0/en unknown
- 2007-01-29 ZA ZA200700823A patent/ZA200700823B/xx unknown
- 2007-02-21 NO NO20070996A patent/NO20070996L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501776A5 (cg-RX-API-DMAC7.html) | ||
| Norden et al. | Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function | |
| EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
| DE602005018763D1 (de) | Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität | |
| WO2007128761A3 (de) | Verwendungen von dpp iv inhibitoren | |
| WO2009021521A3 (en) | Use of gaboxadol for the manufacture of a medicament for treating stress-mediated depression | |
| RU2012124268A (ru) | Бензимидазольные соединения и их применения | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| JP2004517824A5 (cg-RX-API-DMAC7.html) | ||
| JP2008508253A5 (cg-RX-API-DMAC7.html) | ||
| RU2008116567A (ru) | Биомаркеры | |
| UA99094C2 (ru) | Способ лечения пациента с системной красной волчанкой | |
| Ren et al. | Effect of intermittent pneumatic compression with different inflation pressures on the distal microvascular responses of the foot in people with type 2 diabetes mellitus | |
| EA200870088A1 (ru) | Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови | |
| RU2007103332A (ru) | Способы лечения опосредуемых ccr2 заболеваний или нарушений | |
| JP2023531675A5 (cg-RX-API-DMAC7.html) | ||
| NO20055531L (no) | Preparat for forbedret kognisjon og hukommelse | |
| JP2003528919A5 (cg-RX-API-DMAC7.html) | ||
| RU2013112890A (ru) | Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина | |
| TW200833345A (en) | Use of vitamin D compounds and mimics thereof to enhance delivery of therapeutics and oxygen to tumors and other tissues | |
| MX2009004646A (es) | Agente que comprende g-csf para la prevencion y el tratamiento de la neuropatia periferica diabetica. | |
| ATE487480T1 (de) | Perhexilin zur behandlung von chronischer herzinsuffizienz | |
| Yong et al. | Electroacupuncture pretreatment attenuates brain injury in a mouse model of cardiac arrest and cardiopulmonary resuscitation via the AKT/eNOS pathway | |
| ATE446309T1 (de) | Den kapillarwiderstand verbessernde peptidsubstanz, darauf basierende pharmazeutische zusammensetzung und verfahren zu deren anwendung |